ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2696

Identification of a Potential Commensal Immunologic Target in Enthesitis-Related Arthritis

Matthew L. Stoll1, Lennard W. Duck2, Randy Q. Cron3 and Charles O. Elson4, 1University of Alabama at Birmingham, Birmingham, AL, 2Medicine, University of Alabama at Birmingham, Birmingham, AL, 3Pediatric Rheumatology, Children's Hospital of Alabama, Birmingham, AL, 4Dept of Medicine, University of Alabama at Birmingham, Birmingham, AL

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Spondylarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Identification of a Potential Commensal Immunologic Target in Enthesitis-related Arthritis

Background/Purpose: Research in inflammatory bowel disease (IBD) has identified commensal organisms that stimulate humoral and T cell immune responses. Although there is mixed data on whether similar antibodies are also present in spondyloarthritis (SpA), there has not been a comprehensive effort to identify commensal antigenic targets in SpA.

Methods: We used a novel antigen array developed by one of the co-authors (1) in which lysates of whole bacteria were plated, along with known flagellar and other commensal-derived antigens. Initial screening was performed with pooled serum samples from children with enthesitis-related arthritis (ERA) and healthy control subjects, testing for IgG and IgA reactivity. Validation was performed with Western blots and with individual serum samples on the array.

Results: The initial screening studies were performed on pools of five ERA subjects and healthy controls. For most of the antigens tested on the array, there were no differences in binding between ERA patients and controls. However, IgG and IgA reactivity against Prevotella oralis was present only in the patients with ERA, not in controls or even in the pool of patients with ERA complicated by IBD. Western blots against P. oralis with ERA serum identified a high molecular weight glycoprotein that was not targeted by control serum. To confirm our findings, we repeated the array on individual serum samples from 83 patients with ERA (44 male; age 13; 6.0  – 19) and 59 healthy control subjects (33 male; age 13; 6.6 – 18). While there were no differences in IgG or IgA reactivity to most antigens, including the positive control Tetanus toxoid, ERA subjects had increased IgA reactivity against P. oralis (net signal intensity [NSI] 3761 versus 1835, p  = 0.008; Figure) as well as to P. buccalis (NSI 962 versus 618, p = 0.008.) ERA patients also had increased IgG reactivity against P. buccalis (NSI 4936 versus 2718, p = 0.003) as well as a modest increase against the previously identified IBD-associated antigen Fla2 (NSI 1310 versus 1007, p = 0.026). Among the ERA patients, there was no association between HLA-B27 status and reactivity against these antigens.

Conclusion: Herein, we introduce members of the Prevotella genus, primarily P. oralis and P. buccalis, as potential antigenic targets in children with ERA. We also demonstrate increased Fla2 reactivity in children with ERA, consistent with data in adults with SpA. (1) Christmann B et al., JACI 2015;136:1378-86


Disclosure: M. L. Stoll, None; L. W. Duck, None; R. Q. Cron, None; C. O. Elson, Prometheus Laboratories, Inc., 7.

To cite this abstract in AMA style:

Stoll ML, Duck LW, Cron RQ, Elson CO. Identification of a Potential Commensal Immunologic Target in Enthesitis-Related Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/identification-of-a-potential-commensal-immunologic-target-in-enthesitis-related-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-a-potential-commensal-immunologic-target-in-enthesitis-related-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology